Infantile Aspergillus fumigatus ventriculitis successfully treated with monitoring of plasma and cerebrospinal fluid voriconazole concentration level.

[1]  D. K. Benjamin,et al.  Voriconazole Treatment for an Infant With Intractable Candida glabrata Meningitis. , 2018, The Pediatric infectious disease journal.

[2]  K. Kamei,et al.  Nationwide survey of neonatal invasive fungal infection in Japan , 2018, Medical mycology.

[3]  M. Finkelman,et al.  (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients. , 2016, Journal of the Pediatric Infectious Diseases Society.

[4]  Kunihiko Kobayashi,et al.  Voriconazole Concentrations in Cerebrospinal Fluid During Prophylactic Use in Children with Acute Myelogenous Leukemia , 2016, The Pediatric infectious disease journal.

[5]  S. Rosenbaum,et al.  Developmental pharmacokinetics in pediatric populations. , 2014, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

[6]  H. Shimada,et al.  Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age , 2010, Pediatric blood & cancer.

[7]  R. Jelliffe,et al.  Voriconazole pharmacokinetics and pharmacodynamics in children. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Mats O. Karlsson,et al.  Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies , 2008, Antimicrobial Agents and Chemotherapy.

[9]  M. Mostert,et al.  Risk Factors for Progression to Invasive Fungal Infection in Preterm Neonates With Fungal Colonization , 2006, Pediatrics.

[10]  F. Eifinger,et al.  Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight , 2006, Journal of Perinatology.

[11]  W. McGuire,et al.  Invasive fungal infection in very low birthweight infants: national prospective surveillance study , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[12]  A. Rettie,et al.  Developmental Expression of Human Hepatic CYP2C9 and CYP2C19 , 2004, Journal of Pharmacology and Experimental Therapeutics.

[13]  S. Roffey,et al.  Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  C. Byington,et al.  Perinatal/Neonatal Case Presentation: Aspergillosis in a 24-Week Newborn: A Case Report , 2003, Journal of Perinatology.

[15]  C. Viscoli,et al.  Aspergillus Galactomannan Antigen in the Cerebrospinal Fluid of Bone Marrow Transplant Recipients with Probable Cerebral Aspergillosis , 2002, Journal of Clinical Microbiology.